AU2003901425A0 - A diagnostic method for epilepsy - Google Patents

A diagnostic method for epilepsy

Info

Publication number
AU2003901425A0
AU2003901425A0 AU2003901425A AU2003901425A AU2003901425A0 AU 2003901425 A0 AU2003901425 A0 AU 2003901425A0 AU 2003901425 A AU2003901425 A AU 2003901425A AU 2003901425 A AU2003901425 A AU 2003901425A AU 2003901425 A0 AU2003901425 A0 AU 2003901425A0
Authority
AU
Australia
Prior art keywords
epilepsy
diagnostic method
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003901425A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionomics Ltd
Original Assignee
Bionomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionomics Ltd filed Critical Bionomics Ltd
Priority to AU2003901425A priority Critical patent/AU2003901425A0/en
Publication of AU2003901425A0 publication Critical patent/AU2003901425A0/en
Priority to DK04718885.9T priority patent/DK1606418T3/da
Priority to EP04718885.9A priority patent/EP1606418B1/en
Priority to AU2004200978A priority patent/AU2004200978B2/en
Priority to CA2520271A priority patent/CA2520271C/en
Priority to ES04718885.9T priority patent/ES2478624T3/es
Priority to PCT/AU2004/000295 priority patent/WO2004085674A1/en
Priority to NZ542202A priority patent/NZ542202A/en
Priority to JP2006503959A priority patent/JP2006524490A/ja
Priority to US10/806,899 priority patent/US7723027B2/en
Priority to US12/767,523 priority patent/US8288096B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003901425A 2003-03-27 2003-03-27 A diagnostic method for epilepsy Abandoned AU2003901425A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AU2003901425A AU2003901425A0 (en) 2003-03-27 2003-03-27 A diagnostic method for epilepsy
JP2006503959A JP2006524490A (ja) 2003-03-27 2004-03-10 てんかんを診断および処置するための方法
CA2520271A CA2520271C (en) 2003-03-27 2004-03-10 Methods for the diagnosis and treatment of epilepsy
EP04718885.9A EP1606418B1 (en) 2003-03-27 2004-03-10 Methods for the diagnosis and treatment of epilepsy
AU2004200978A AU2004200978B2 (en) 2003-03-27 2004-03-10 A diagnostic method for epilepsy
DK04718885.9T DK1606418T3 (da) 2003-03-27 2004-03-10 Fremgangsmåder til diagnosticering og behandling af epilepsi
ES04718885.9T ES2478624T3 (es) 2003-03-27 2004-03-10 Métodos para el diagnóstico y el tratamiento de la epilepsia
PCT/AU2004/000295 WO2004085674A1 (en) 2003-03-27 2004-03-10 Methods for the diagnosis and treatment of epilepsy
NZ542202A NZ542202A (en) 2003-03-27 2004-03-10 Methods for the diagnosis and treatment of epilepsy
US10/806,899 US7723027B2 (en) 2003-03-27 2004-03-23 Methods for the diagnosis and treatment of epilepsy
US12/767,523 US8288096B2 (en) 2003-03-27 2010-04-26 Diagnostic method for epilepsy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003901425A AU2003901425A0 (en) 2003-03-27 2003-03-27 A diagnostic method for epilepsy

Publications (1)

Publication Number Publication Date
AU2003901425A0 true AU2003901425A0 (en) 2003-04-10

Family

ID=31500468

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003901425A Abandoned AU2003901425A0 (en) 2003-03-27 2003-03-27 A diagnostic method for epilepsy

Country Status (9)

Country Link
US (2) US7723027B2 (https=)
EP (1) EP1606418B1 (https=)
JP (1) JP2006524490A (https=)
AU (1) AU2003901425A0 (https=)
CA (1) CA2520271C (https=)
DK (1) DK1606418T3 (https=)
ES (1) ES2478624T3 (https=)
NZ (1) NZ542202A (https=)
WO (1) WO2004085674A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR220300A0 (en) 2000-12-20 2001-01-25 Bionomics Limited New epilepsy gene
US7709225B2 (en) * 2001-07-18 2010-05-04 Bionomics Limited Nucleic acids encoding mutations in sodium channels related to epilepsy
AU2003904154A0 (en) 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
JP2005501536A (ja) 2001-07-18 2005-01-20 バイオノミックス リミテッド イオンチャネルにおける変異
AU2003901425A0 (en) 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy
EP1904630A4 (en) * 2005-06-16 2009-10-21 Bionomics Ltd METHODS OF TREATING AND DIAGNOSING EPILEPSY BY DETECTING MUTATIONS OF THE SCN1A GENE
US20090304747A1 (en) * 2006-05-16 2009-12-10 Mayo Foundation For Medical Education And Research Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
US20130036482A1 (en) 2010-01-29 2013-02-07 National University Corporation Okayama University Method for assessment of potential for development of dravet syndrome and use thereof
CN109112126B (zh) 2010-06-23 2024-06-14 库尔纳公司 通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病
JP2018531975A (ja) * 2015-10-30 2018-11-01 ピーティーシー セラピューティクス，インコーポレーテッド てんかんの治療方法
WO2019224864A1 (ja) * 2018-05-21 2019-11-28 国立研究開発法人理化学研究所 Ｓｃｎ１ａ遺伝子の発現増強法とそれによるドラベ症候群の治療法
CN113197585B (zh) * 2021-04-01 2022-02-18 燕山大学 一种神经肌肉信息交互模型构建及参数辨识优化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4474893A (en) 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4971903A (en) 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
NO175199C (no) 1991-12-05 1994-09-14 Kvaerner Fjellstrand As Flerskrogfartöy
US5646040A (en) 1995-06-30 1997-07-08 Millennium Pharmaceutical, Inc. Mammalian tub gene
US6331614B1 (en) * 1998-12-23 2001-12-18 Myriad Genetics, Inc. Human CDC14A gene
DE1252330T1 (de) * 1999-11-26 2003-11-27 Mcgill University, Montreal Loci der idiopathischen epilepsie, mutationen derselben und verfahren zu deren verwendung zur feststellung, prognose und behandlung von epilepsie
US6331573B1 (en) * 2000-02-29 2001-12-18 Chevron U.S.A. Inc. Increased liquid sensitivity during fischer-tropsch synthesis by olefin incorporation
AUPQ749100A0 (en) 2000-05-12 2000-06-08 Bionomics Limited New epilespy gene
ATE437948T1 (de) 2000-06-20 2009-08-15 Bionomics Ltd Mutation, welche mit epilepsie assoziiert ist
AUPQ882600A0 (en) 2000-07-18 2000-08-10 Bionomics Limited Mutations in ion channels
AUPR220300A0 (en) * 2000-12-20 2001-01-25 Bionomics Limited New epilepsy gene
US7282336B2 (en) 2001-07-18 2007-10-16 Bionomics Limited Method of diagnosing epilepsy
JP2005501536A (ja) * 2001-07-18 2005-01-20 バイオノミックス リミテッド イオンチャネルにおける変異
AU2003904154A0 (en) 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
US7709225B2 (en) 2001-07-18 2010-05-04 Bionomics Limited Nucleic acids encoding mutations in sodium channels related to epilepsy
US20030157525A1 (en) 2001-11-26 2003-08-21 Mintier Gabriel A. Novel human G-protein coupled receptor, HGPRBMY31, and variants and methods of use thereof
AU2003901425A0 (en) 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy
EP1904630A4 (en) 2005-06-16 2009-10-21 Bionomics Ltd METHODS OF TREATING AND DIAGNOSING EPILEPSY BY DETECTING MUTATIONS OF THE SCN1A GENE

Also Published As

Publication number Publication date
US20100203548A1 (en) 2010-08-12
CA2520271C (en) 2014-09-23
JP2006524490A (ja) 2006-11-02
EP1606418A4 (en) 2006-11-22
US8288096B2 (en) 2012-10-16
DK1606418T3 (da) 2014-07-14
EP1606418B1 (en) 2014-05-07
ES2478624T3 (es) 2014-07-22
US20040229257A1 (en) 2004-11-18
EP1606418A1 (en) 2005-12-21
NZ542202A (en) 2009-07-31
CA2520271A1 (en) 2004-10-07
WO2004085674A1 (en) 2004-10-07
US7723027B2 (en) 2010-05-25

Similar Documents

Publication Publication Date Title
GB0317493D0 (en) A method
AU2003208489A1 (en) Method for desinging a well completion
AU2003296732A1 (en) Method for producing polycarbonates
AU2003901583A0 (en) A process
AU2003900226A0 (en) A filter system
AU2003901425A0 (en) A diagnostic method for epilepsy
PT1606448E (pt) Processo para a produção de um cabo de aço
AU2003272267A1 (en) A diagnostic method for manufacturing processes
AU2003296221A1 (en) A general charging method
IL176376A0 (en) Method for analyzing a glycomolecule
EP1603386B8 (fr) Procede d'aquaculture
AU2003269047A1 (en) Method for making biochips
AU2003263714A1 (en) Method for obtaining a fraction
AU2003905565A0 (en) A diagnostic method for epilepsy
AU2003206283A1 (en) Preventing method for a vehicle
AU2003900068A0 (en) A sprinker system
AU2003271245A1 (en) Method for producing a nitrogen-potash fertiliser
AU2003257058A1 (en) Method for making alkyhalosilanes
GB0324255D0 (en) Diagnostic method
AU2003261580A1 (en) A method for identifying the channels
AU2003271244A1 (en) Method for producing a nitrogen-potassium fertiliser
AU2003900318A0 (en) A method for multiple devices
AU2003900337A0 (en) A method for a single device
AU2003905593A0 (en) Methylation-based diagnostic method
AU2004904200A0 (en) A mounting method